China · 
Who invested in NovaMed Pharmaceuticals?
NovaMed Pharmaceuticals's investors include Atlas Venture, Fidelity Biosciences and Fidelity Growth Partners Asia.
2008
$5.0MSeries A$14MSeries B
China · Series B startup
Who invested in NovaMed Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$19Mraised across 2 rounds since 2007, from 2 sources
$5.0MSeries A$14MSeries B
- Latest round
- Series B, $14MJan 2008
- Step-upi
- 2.8×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $5.0M Jul 2007
- Biggest round
- $14M Series B · Jan 2008
- Between rounds
- 6 months from the last two
The rounds
- Jan 2008Series B$14M2 new1 returning
From a historical funding record
- Jul 2007
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Fidelity BiosciencesInvestment firm1round
Fidelity Growth Partners AsiaInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about NovaMed Pharmaceuticals
How much has NovaMed Pharmaceuticals raised?
NovaMed Pharmaceuticals has raised $19M across 2 rounds since 2007.
When did NovaMed Pharmaceuticals last raise?
NovaMed Pharmaceuticals's most recent round was a Series B of $14M in Jan 2008.
What was NovaMed Pharmaceuticals's biggest round?
Its most recent round, $14M in Jan 2008, is also its largest on record.
Who backed NovaMed Pharmaceuticals first?
NovaMed Pharmaceuticals's first round on record, in Jul 2007, was backed by Atlas Venture.
What stage is NovaMed Pharmaceuticals at?
NovaMed Pharmaceuticals's latest named round is a Series B, in Jan 2008.
Where is NovaMed Pharmaceuticals based?
NovaMed Pharmaceuticals is based in China.
Companies like NovaMed Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.